FR2361335A1 - 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol - Google Patents

4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol

Info

Publication number
FR2361335A1
FR2361335A1 FR7703602A FR7703602A FR2361335A1 FR 2361335 A1 FR2361335 A1 FR 2361335A1 FR 7703602 A FR7703602 A FR 7703602A FR 7703602 A FR7703602 A FR 7703602A FR 2361335 A1 FR2361335 A1 FR 2361335A1
Authority
FR
France
Prior art keywords
naphtalenetriol
substitue
hydroxypropoxy
tetrahydro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7703602A
Other languages
English (en)
Other versions
FR2361335B1 (fr
Inventor
Frederic P Hauck
Michael E Condon
Rita T Fox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2361335A1 publication Critical patent/FR2361335A1/fr
Application granted granted Critical
Publication of FR2361335B1 publication Critical patent/FR2361335B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des composés de formule :
FR7703602A 1976-02-09 1977-02-09 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol Granted FR2361335A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/656,769 US4048231A (en) 1976-02-09 1976-02-09 4-[3-(Substituted amino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols

Publications (2)

Publication Number Publication Date
FR2361335A1 true FR2361335A1 (fr) 1978-03-10
FR2361335B1 FR2361335B1 (fr) 1980-04-30

Family

ID=24634483

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703602A Granted FR2361335A1 (fr) 1976-02-09 1977-02-09 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol

Country Status (18)

Country Link
US (2) US4048231A (fr)
JP (1) JPS5943454B2 (fr)
AT (1) AT349011B (fr)
AU (1) AU509744B2 (fr)
BE (1) BE850452A (fr)
CA (1) CA1105483A (fr)
CH (1) CH618676A5 (fr)
DE (1) DE2701626A1 (fr)
DK (1) DK51877A (fr)
FR (1) FR2361335A1 (fr)
GB (2) GB1564160A (fr)
HU (1) HU173781B (fr)
IE (1) IE45258B1 (fr)
NL (1) NL7700421A (fr)
NO (1) NO770415L (fr)
PL (1) PL108213B1 (fr)
SE (1) SE7701390L (fr)
ZA (1) ZA767572B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003664B1 (fr) * 1978-02-08 1982-02-17 Imperial Chemical Industries Plc Dérivés d'alcanolamines, procédé pour leur préparation et compositions pharmaceutiques les contenant
JPS6241829Y2 (fr) * 1980-03-28 1987-10-26
FR2507181A1 (fr) 1981-06-05 1982-12-10 Sanofi Sa Nouveaux ethers de phenol actifs sur le systeme cardiovasculaire, leur procede de preparation et leur utilisation dans des medicaments
KR101430838B1 (ko) * 2009-09-11 2014-08-18 가부시키가이샤 리코 치환기 이탈 화합물, 유기 반도체 재료, 상기 재료를 포함하는 유기 반도체 막, 상기 막을 포함하는 유기 전자 디바이스, 막상체의 제조 방법, π-전자 공역계 화합물 및 π-전자 공역계 화합물의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543344A1 (de) * 1966-04-22 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen 1-Amino-3-aryloxypropanol-2-aethern
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen

Also Published As

Publication number Publication date
BE850452A (fr) 1977-07-18
DE2701626A1 (de) 1977-08-11
US4048231A (en) 1977-09-13
NO770415L (no) 1977-08-10
PL108213B1 (pl) 1980-03-31
DK51877A (da) 1977-08-10
IE45258B1 (en) 1982-07-28
FR2361335B1 (fr) 1980-04-30
CH618676A5 (fr) 1980-08-15
AU2089076A (en) 1978-06-29
IE45258L (en) 1977-08-09
JPS5943454B2 (ja) 1984-10-22
GB1564160A (en) 1980-04-02
SE7701390L (sv) 1977-08-10
NL7700421A (nl) 1977-08-11
AT349011B (de) 1979-03-12
GB1564159A (en) 1980-04-02
HU173781B (hu) 1979-08-28
US4093814A (en) 1978-06-06
CA1105483A (fr) 1981-07-21
ATA77977A (de) 1978-08-15
JPS5297953A (en) 1977-08-17
ZA767572B (en) 1977-11-30
AU509744B2 (en) 1980-05-22

Similar Documents

Publication Publication Date Title
FR2442849A1 (fr)
FR2453145A1 (fr)
FR2379534A1 (fr) 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees
FR2371453A1 (fr) Thiadiazolotriazinediones substituees, leur preparation et leur utilisation comme herbicides et comme agents antiviraux et antimicrobiens
FR2375218A1 (fr) 2-imidazoline-5-ones a substitution chirale
FR2389605A1 (fr)
FR2392007A1 (fr) 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy-piperidines, leurs derives, leur preparation et leur utilisation comme antidiarrheiques et analgesiques
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
FR2383605A1 (fr) Regulateurs de la croissance des vegetaux
FR2369259A1 (fr) Derives de 3,3-dichloro-2-azetidinone ayant une activite anti-inflammatoire
FR2372165A1 (fr)
FR2369276A1 (fr) Nouve
FR2361335A1 (fr) 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol
FR2389597A1 (fr)
FR2446284A1 (fr) Tetrahydro-benzo(c)quinoleine-9(8h)ones
FR2355500A1 (fr) Composition antimicrobienne a base de 1-acyloxy-2-imidazolyl-1-phenylethanes
FR2389615A1 (fr)
FR2362148A1 (fr) Composes silices polyethyleniques
FR2429778A1 (fr) Nouvelles n,n'-bis((n-cyano-n'-alcynyl)methanimidamidyl)-cystamines
FR2446835A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines utiles comme intermediaires
FR2434805A1 (fr) 1-benzoyl-3-pyridinylurees, leur preparation et leur utilisation comme insecticides
FR2389631A1 (fr)
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
FR2389624A1 (fr)
FR2415619A1 (fr) 3-chloro-2,6-dinitro-n-(phenyl substitue)-4-(trifluoromethyl) benzenamines fongicides

Legal Events

Date Code Title Description
ST Notification of lapse